- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01210326
The Comparison of Diagnostic TESE and TESA in Non-obstructive Azoospermic
July 14, 2011 updated by: Royan Institute
The Comparison of Diagnostic Testicular Sperm Extraction(TESE) and Testicular Sperm Aspiration(TESA) in Non-obstructive Azoospermic Patients a Randomized Clinical Trial Study
Azoospermia , as the name suggests , refers to the condition in which there are no sperm in the semen.
This diagnosis can come as a rude shock, because most men with a zero sperm count have normal libido; normal sexual function; and their semen looks completely normal too.
The diagnosis can only be made by examining the semen under a microscope in the laboratory.Men with non-obstructive azoospermia have a normal passageway, but abnormal testicular function, and their testes do not produce sperm normally.
Some of these men may have small testes on clinical examination.
The testicular failure may be partial, which means that only a few areas of the testes produce sperm, but this sperm production is not enough for it to be ejaculated.
Other men may have complete testicular failure, which means there is no sperm production at all in the entire testes.
The only way to differentiate between complete and partial testicular failure is by doing multiple testicular micro-biopsies to sample different areas of the testes and send them for pathological examination.
This technique is called TESA, or testicular sperm aspiration ( also known as TESE, or testicular sperm extraction) or mTESE ( micro-testicular sperm extraction).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study was performed on 180 men with non-obstructive azoospermia (NOA), referring to royan infertility center, according to inclusion and exclusion criteria.
Testis selection (right and left) and techniques (TESE or TESA) were performed randomly in patients.
For every patient based on random order, TESA or TESE was performed as the following procedures.
The testis was aspirated at three separated sites (upper, middle and lower pole), using 20 ml syringe and 18-gauge needle or testicular biopsy (TESE) was taken from the same 3 sites.
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tehran, Iran, Islamic Republic of
- Royan Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Non obstructive Azoospermia
- No Previous biopsy
Exclusion Criteria:
- Atrophic testis
- FSH levels more than 4 times normal range
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: aspiration
90 patients with non-obstructive azoospermi undergo testicular sperm aspiration
|
testicular sperm aspiration
Other Names:
|
|
Experimental: extraction
90 patients with non-obstructive azoospermi undergo testicular sperm extraction
|
TESE (testicular sperm extraction), which is actually a surgical biopsy of the testis; or TESA (testicular sperm aspiration), which is performed by sticking a needle in the testis and aspirating fluid and tissue with negative pressure
Other Names:
testicular sperm extraction
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sperm retrieval
Time Frame: 6 months
|
comparision the success of sperm retrieval with TESE and TESA
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Side effects
Time Frame: 6 months
|
Evaluate the side effects of the procedures like bleeding, inflammation, infection
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: hamid gourabi, PhD, President of Royan Institute
- Principal Investigator: Jalil Hosseini, MD, urology investigator
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
July 1, 2010
Study Completion (Actual)
September 1, 2010
Study Registration Dates
First Submitted
September 27, 2010
First Submitted That Met QC Criteria
September 27, 2010
First Posted (Estimate)
September 28, 2010
Study Record Updates
Last Update Posted (Estimate)
July 15, 2011
Last Update Submitted That Met QC Criteria
July 14, 2011
Last Verified
August 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Royan-Emb-009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)
Clinical Trials on testicular sperm aspiration
-
Herlev and Gentofte HospitalUniversity of Michigan; Rigshospitalet, Denmark; Holbaek Sygehus; Skane University...CompletedNon-obstructive AzoospermiaDenmark, Sweden
-
Assiut UniversityNot yet recruitingTesticular Sperm Extraction in Azoospermic Patients
-
Clinic and Research Center in Human Reproduction...CompletedInfertility | AzoospermiaBrazil
-
Istituto Clinico HumanitasRecruiting
-
Cairo UniversityCompletedAzoospermia Anogenital Distance AMHEgypt
-
Cairo UniversityCompletedNon Obstructive AzoospermiaEgypt
-
Ganin Fertility CenterCompleted
-
South Valley UniversityCompletedMale Infertility | Azoospermia, NonobstructiveEgypt
-
Hadassah Medical OrganizationRecruiting
-
Assiut UniversityNot yet recruitingMale Infertility Due to Azoospermia